贝罗司他胶囊国内价格是多少钱
Orladeyo is a plasma kallikrein inhibitor that binds to plasma kallikrein and inhibits its proteolytic activity. The approval of the drug will bring significant progress in the treatment of patients with hereditary angioedema HAE and will help reduce the treatment burden on patients. Today let’s find out how much is the domestic price of berosstat capsules?
Recently, many patients have learned that because Orladeyo is not currently on the market in our country, let alone medical insurance, the drug can only be obtained from abroad, and the price of the foreign version is very expensive. If patients want Orladeyo, they can obtain the drug through domestic professional overseas medical service organizations (such as Medical Companion Travel), which is more cost-effective. The price is not fixed due to exchange rate fluctuations. For specific prices, please consult the Medical Companion Travel Service.
Berostat capsule Orladeyo is the first targeted oral therapy approved to prevent HAE attacks. The recommended dose of berostat is: one capsule (150 mg) taken orally once daily with food. During treatment with Orladeyo capsules, patients should not increase or decrease the dose of the drug without authorization. Increasing the dose of the drug will not make the condition improve quickly, but will lead to adverse reactions. Therefore, patients should strictly follow the doctor's diagnosis and treatment recommendations and should not use drugs without authorization.
In the pivotal Phase 3 APeX-2 trial, BioCryst significantly reduced the number of hereditary angioedema HAE attacks over 24 weeks and continued through week 48. Patients who completed the 48-week trial experienced a significant reduction in the frequency of hereditary angioedema HAE attacks, from an average of 2.9 attacks/month at baseline to an average of 1 attack/month.
Completion of another long-term open-label APeX-S study reduced the frequency of HAE attacks in patients with hereditary angioedema to an average of 0.8 episodes per month. It can be seen that the therapeutic effect of beroxostat capsule Orladeyo is very significant, and the successful development of this drug is good news for many patients.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended related articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)